Home > Boards > US OTC > Basic Materials > Bioxytran Inc. (BIXT)

$ BIXT Future use of the MDX Viewer likely

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
jedijazz Member Profile
Member Level 
Followed By 1,150
Posts 166,459
Boards Moderated 49
Alias Born 12/07/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 3/26/2020 6:53:40 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/18/2020 3:47:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/12/2020 8:01:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/12/2020 6:06:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2020 6:06:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2020 2:35:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/15/2020 4:01:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/10/2020 2:40:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/6/2020 4:27:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2019 7:53:53 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2019 5:09:27 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 1:20:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 3:09:24 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 11/5/2019 3:36:26 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 11/5/2019 1:51:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/28/2019 9:14:38 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 2:57:37 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 3:55:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 3:33:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2019 9:03:15 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/30/2019 9:51:25 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/30/2019 9:49:39 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/30/2019 9:47:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2019 1:30:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 2:47:11 PM
jedijazz Member Level  Monday, 05/20/19 12:10:47 PM
Re: None
Post # of 615 
$BIXT Future use of the MDX Viewer likely to start in operating rooms, clinical trials to measure tissue balance in stroke, and to test the viability of an organ before transplantation

BOSTON, MASSACHUSETTS, May 20, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by delivering a small molecule carrying oxygen to the brain of stroke victims announced today that the Journal of Emergency Medicine and Care published a peer reviewed article that describes a revolutionary new vital sign called the Tissue Metabolic Score (TMS).

https://finance.yahoo.com/news/bioxytran-using-paradigm-changing-vital-110533064.html


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist